Skip navigation

Renishaw news

Latest company and product news from Renishaw  

  • New development for XM-60 offers easy alignment for stage builders

    Horizontal stage on linear stage Users of Renishaw’s leading XM-60 multi-axis calibrator can now benefit from a new single-axis horizontal stage. This enables precise alignment in applications without an axis perpendicular to the travel. Precision translation of the XM-60 launch unit is easily achieved with the horizontal stage, without disturbing yaw alignment. This feature is particularly useful for applications such as stages and printers.

  • Renishaw launches flexible and cost-effective arc encoder range

    RKL partial arc Renishaw, the global metrology specialist, introduces a new range of encoder solutions for partial arc measurement applications. Partial arc capability is now available across all variants of RKL scale, supporting incremental and absolute measurement with the ViONiC™, TONiC™, QUANTiC™, ATOM™, ATOM DX™ and RESOLUTE™ encoder readheads.

  • Biome makes waves with Renishaw's additive manufacturing expertise

    3D printed ocean turbine parts being made Global engineering technologies company, Renishaw, has collaborated with the Nova Scotia Community College (NSCC) in Canada, to produce two ocean turbine parts using additive manufacturing (AM) for industrial design firm Biome Renewables.

  • Simufact and Renishaw collaborate to streamline additive manufacturing simulation and build file preparation

    Simufact team Global engineering company, Renishaw, is collaborating with Simufact to enhance the success of laser powder bed fusion (LPBF) builds through accurate simulation and streamlined additive manufacturing (AM) build preparation. The collaboration includes the integration of Renishaw’s QuantAM build preparation software into Simufact Additive 2020, announced at Formnext 2019.

  • Renishaw announces completion of the main part of a multi-centre clinical trial

    Renishaw's novel intraparenchymal drug delivery system Global engineering technologies company, Renishaw, announces that its award-winning intraparenchymal drug delivery device, has played a critical role in a joint Phase 1-2 clinical study with Herantis Pharma plc, for the investigation of cerebral dopamine neurotrophic factor (CDNF) as a treatment for Parkinson's disease.

News stories by category